Therapeutic Areas
Urology
A wide range of preclinical models of urological diseases.
Nephrology
An expertise on preclinical models for kidney pathologies
Oncology
From cells and organoids to human tumors-xenografts models.
Gynecology
A wide range of preclinical models of gynecological diseases.
Andrology
A wide range of preclinical models of males diseases.
Gastroenterology
An expertise on major gastrointestinal diseases.
Our
Platform
Our Platform
With an optimized platform and a pharmaceutical industry level of quality, Urosphere’s Platform offers over a decade of expertise and know-how in preclinical drug development through its in vivo and in vitro models.

News & Publications
News &
Publications
Urosphere will be present 2 posters at the AACR annual meeting 2025
Our team is eagerly awaiting to meet-up with you at Booth no.538 to share how our latest services and models can help bring your research programs a step further. Poster #50:Bidan N. et al., Development of paired enfortumab vedotin-resistant urothelial cancer models using organoid and PDX. Poster #3996:Decaup E. et al., Organoids and immune cells co-culture for evaluating the efficacy of Enfortumab Vedotin and pembrolizumab combination therapy.
Antinociceptive properties of intravesical/needle-free administration of abobotulinumtoxinA in a rodent model of chronic visceral pain: in vivo and histological evidence
Augé C. et al., 2025. Journal of Neural Transmission
Urosphere presented at the European Association of Urology congress 2025
Urosphere presented an oral communication at the EAU congress. Abstract session 30: Decaup E. et al., ESTABLISHING A MIRROR BIOBANK OF PDX-DERIVED ORGANOIDS AS A POWERFUL TOOL FOR DRUG DISCOVERY.
Research &
Development
Research & Development

Our Partners








Our Company
As a member of the drug discovery value chain, Urosphere can support your project. Our experts and platforms are dedicated to meeting your needs. Our aim is to understand your challenges and objectives to develop customized solutions together.